ArticleACS omega2019

Structure-Based Design of Dimeric Bisbenzimidazole Inhibitors to an Emergent Trimethoprim-Resistant Type II Dihydrofolate Reductase Guides the Design of Monomeric Analogues.

Jacynthe L Toulouse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.